Data/hora: 24/06/2024 06:00:50

Biblioteca(s): | Embrapa Pecuária Sul.
Data corrente: | 21/12/2022
Data da última atualização: | 21/12/2022
Autoria: | PORTILHO, A. I.; CORREA, V. A.; GASPAR, E. B.; DE GASPARI, E.
Afiliação: | AMANDA IZELI PORTILHO, Instituto Adolfo Lutz; VICTOR ARAUJO CORREA, Instituto Adolfo Lutz; EMANUELLE BALDO GASPAR, CPPSUL; ELIZABETH DE GASPARI, Instituto Adolfo Lutz.
Título: | Different platforms, immune response modulators and challenges in SARS-COV-2 vaccination.
Ano de publicação: | 2022
Fonte/Imprenta: | Zurich: Springer, 2022.
Páginas: | p. 539-559.
DOI: | 10.1007/978-3-031-08045-6_26
Idioma: | Inglês
Conteúdo: | Vaccination is one of the most powerful measures to control infectious diseases. Nowadays, technical advances allowed the recognition of key aspects of pathogen?host interaction and the spread of such information, which was applied in vaccine development. The urge to control the COVID-19 pandemic resulted in vaccines development in record time, approximately 1 year after the emergence of SARS-CoV-2. The use of classic and innovative vaccine platforms and adjuvants was employed at several locations, by different groups. Here, we discuss how the pandemic scenario influences vaccine development, the implications of the route of immunization and adjuvant choice for vaccines, and the need to consider all these aspects in relation to the current scenario, also preparing ourselves to future pandemics.
Thesagro: | Imunidade; Imunização; Vacina; Vírus.
Categoria do assunto: | H Saúde e Patologia
Registro original: | Embrapa Pecuária Sul (CPPSUL)
Exemplares: | CPPSUL - (14971-1) - UPC - PL - DD -  -  -  - DIS